A week after closing a $14 million acquisition, Phase Forward inked a multi-year, multi-million-dollar deal with Novo Nordisk to provide clinical trials software to the Danish pharmaceuticals colossus.

The Waltham clinical trials software provider will supply its InForm electronic data capture platform to the diabetes and hemophilia treatment developer for all of its clinical trials. Novo Nordisk is already using the EDC product in more than 30 countries.

It’s the latest deal for Phase Forward, which dropped $14 million on Cambridge-based data analysis and reporting software maker Waban Software earlier this month. The company spent $40 million on web-based clinical trials software provider Clarix LLC of Radnor, Pa., last September, Mass High Tech reported.